These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome. Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238 [TBL] [Abstract][Full Text] [Related]
7. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome. Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402 [TBL] [Abstract][Full Text] [Related]
8. Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice. Tao X; Newman-Tancredi A; Varney MA; Razak KA Neuroscience; 2023 Jan; 509():113-124. PubMed ID: 36410632 [TBL] [Abstract][Full Text] [Related]
9. Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome. Razak KA; Binder DK; Ethell IM Front Psychiatry; 2021; 12():720752. PubMed ID: 34690832 [TBL] [Abstract][Full Text] [Related]
10. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice. Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536 [TBL] [Abstract][Full Text] [Related]
11. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome. Wahlstrom-Helgren S; Klyachko VA J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581 [TBL] [Abstract][Full Text] [Related]
12. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838 [TBL] [Abstract][Full Text] [Related]
13. GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using Reyes ST; Mohajeri S; Krasinska K; Guo SG; Gu M; Pisani L; Rosenberg J; Spielman DM; Chin FT Front Mol Neurosci; 2020; 13():612685. PubMed ID: 33390902 [TBL] [Abstract][Full Text] [Related]
14. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice. Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283 [TBL] [Abstract][Full Text] [Related]
15. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948 [TBL] [Abstract][Full Text] [Related]
16. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554 [TBL] [Abstract][Full Text] [Related]
17. Sensory Processing Phenotypes in Fragile X Syndrome. Rais M; Binder DK; Razak KA; Ethell IM ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625 [TBL] [Abstract][Full Text] [Related]
18. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome. Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260 [TBL] [Abstract][Full Text] [Related]
19. Abnormal Sleep Architecture and Hippocampal Circuit Dysfunction in a Mouse Model of Fragile X Syndrome. Boone CE; Davoudi H; Harrold JB; Foster DJ Neuroscience; 2018 Aug; 384():275-289. PubMed ID: 29775702 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome. Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]